Adma Biologics Inc (NASDAQ: ADMA) is 21.69% higher on its value in year-to-date trading and has touched a low of $10.07 and a high of $25.67 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ADMA stock was last observed hovering at around $20.61 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $20.87, the stock is 3.92% and 0.72% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.3 million and changing 1.26% at the moment leaves the stock 11.42% off its SMA200. ADMA registered 98.95% gain for a year compared to 6-month gain of 4.61%. The firm has a 50-day simple moving average (SMA 50) of $20.7198 and a 200-day simple moving average (SMA200) of $18.7312.
The stock witnessed a -1.56% loss in the last 1 month and extending the period to 3 months gives it a 25.65%, and is 2.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.29% over the week and 1.98% over the month.
Adma Biologics Inc (ADMA) has around 685 employees, a market worth around $4.98B and $459.38M in sales. Current P/E ratio is 24.72 and Fwd P/E is 21.22. Profit margin for the company is 45.01%. Distance from 52-week low is 107.15% and -18.70% from its 52-week high. The company has generated returns on investments over the last 12 months (45.52%).
with sales reaching $124.25M over the same period.The EPS is expected to grow by 34.67% this year, but quarterly earnings will post 20.64% year-over-year. Quarterly sales are estimated to grow 15.91% in year-over-year returns.
Adma Biologics Inc (ADMA) Top Institutional Holders
477.0 institutions hold shares in Adma Biologics Inc (ADMA), with institutional investors hold 90.75% of the company’s shares. The shares outstanding are 238.53M, and float is at 230.40M with Short Float at 5.79%. Institutions hold 88.40% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 18.64 million shares valued at $208.45 million. The investor’s holdings represent 8.0221% of the ADMA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 14.52 million shares valued at $162.3 million to account for 6.2459 of the shares outstanding. The other top investors are INVESCO LTD. which holds 13.17 million shares representing 5.6668% and valued at over $147.25 million, while NUVEEN ASSET MANAGEMENT, LLC holds 3.8401 of the shares totaling 8.93 million with a market value of $99.78 million.
Adma Biologics Inc (ADMA) Insider Activity
Still, SEC filings show that on May 21 ’25, Guiheen Lawrence P. (Director) disposed off 7,779 shares at an average price of $20.32 for $0.16 million. The insider now directly holds 114,830 shares of Adma Biologics Inc (ADMA).
